Verona Pharma American Depositary Share retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $-0.579B, a 39.67% increase year-over-year.
Verona Pharma American Depositary Share retained earnings (accumulated deficit) for 2024 were $-0.562B, a 44.79% increase from 2023.
Verona Pharma American Depositary Share retained earnings (accumulated deficit) for 2023 were $-0.388B, a 16.61% increase from 2022.
Verona Pharma American Depositary Share retained earnings (accumulated deficit) for 2022 were $-0.333B, a 26.31% increase from 2021.